| Excluded study |
Interventions |
Reference to Cochrane review if existing |
| Participants ‐ acutely disturbed people |
| Baker 2002 |
'As required' lorazepam versus 'as required' olanzapine ‐ added to initial olanzapine dose |
— |
| Foster 1997 |
'As required' haloperidol versus 'as required' lorazepam |
— |
| Hovens 2005 |
'As required' lorazepam added to initial risperidone versus zuclopenthixol |
— |
| Kinon 2001 |
Haloperidol versus lorazepam plus olanzapine |
— |
| Kinon 2008 |
Aripiprazole versus olanzapine |
Khanna 2014; Komossa 2010
|
| Kramer 1978 |
Loxapine versus thioridazine |
Chakrabarti 2007a; Fenton 2007
|
| Lesem 2001 |
Ziprasidone dosage |
— |
| Potkin 2006 |
Quetiapine versus placebo versus risperidone |
Asmal 2013; Komossa 2011; Lankappa 2012; Rattehalli 2010
|
| Slotnick 1971 |
Chlorpromazine versus haloperidol |
Leucht 2008 |
| Stotsky 1977 |
Haloperidol versus thiothixene |
Dold 2015 |
| Zhang 2013 |
Haloperidol versus ziprasidone |
Bagnall 2000 |
| Participants ‐ newly admitted inpatients with a diagnosis of schizophrenia |
| Maoz 2000 |
Haloperidol plus propranolol versus haloperidol plus placebo |
— |
| Participants ‐ people with schizophrenia |
| Neborsky 1984 |
Haloperidol dosage |
— |
| Participants ‐ people with chronic schizophrenia |
| Huttunen 1996 |
Depot haloperidol dosage |
— |
